CIK 0001620463
- Non-accelerated filer
- Smaller reporting company
LeonaBio, Inc.
Sign in to watch- Ticker
- LONA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 453368487
- Phone
- +1 425-620-8501
- Business address
- 18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL, WA, 98011
- Former names
- Athira Pharma, Inc., M3 Biotechnology, Inc.
- 4 Open-market sale CHIEF SCIENTIFIC OFFICER sold 876 shares at $6.88 ($6,027)
- 4 Open-market sale General Counsel and CCO sold 876 shares at $6.88 ($6,027)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 1,319,026 shares (grant or award)
- 4 Open-market sale CHIEF SCIENTIFIC OFFICER sold 8,526 shares at $0.29 ($2,502)
- 4 Open-market sale President and CEO sold 25,123 shares at $0.29 ($7,374)
- 4 Open-market sale CHIEF MEDICAL OFFICER sold 10,842 shares at $0.29 ($3,182)
- 4 Open-market sale General Counsel and CCO sold 8,526 shares at $0.29 ($2,502)
- 4 Open-market sale SVP, Finance and Accounting sold 2,897 shares at $0.29 ($850)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 3 of 11 · 211 filings